Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05002816
Title Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Yale University
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale New Haven Hospital Recruiting New Haven Connecticut 06512 United States Details
*Shaded cells indicate that there was no data available from for the field